Protocol CAUSE-03 / CHEETAH
Public ClinicalTrials.gov record NCT06136091. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Mechanisms Underlying Asthma Symptoms and Exacerbations Examined Across T2 Status in Children (CHEETAH) (CAUSE-03)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a one-year longitudinal, observational study of 250 urban children and adolescents with asthma and 60 without asthma, ages 6-17 years old. Participants with asthma will require daily controller therapy with inhaled corticosteroids ICS (at least Step 2 therapy). Those without asthma cannot have used asthma medications in the year prior to enrollment and cannot demonstrate bronchodilator reversibility at baseline. Phenotypic characteristics will be established at baseline, and the participants will be seen at scheduled visits over 12 months. Each participant will be asked to monitor and self-report cold symptoms and will be asked to complete up to three cold visits
Study identification
- NCT ID
- NCT06136091
- Recruitment status
- Recruiting
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 310 participants
Conditions and interventions
Conditions
Interventions
Not listed
Eligibility (public fields only)
- Age range
- 6 Years to 17 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 7, 2024
- Primary completion
- Aug 31, 2027
- Completion
- Aug 31, 2027
- Last update posted
- Jun 30, 2026
2024 – 2027
United States locations
- U.S. sites
- 8
- U.S. states
- 6
- U.S. cities
- 6
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Children's Hospital Colorado: Allergy Program | Aurora | Colorado | 80045 | Recruiting |
| Children's National Medical Center: Children's Research Institute | Washington D.C. | District of Columbia | 20010 | Recruiting |
| Ann & Robert H. Lurie Children's Hospital of Chicago: Division of Allergy and Immunology | Chicago | Illinois | 60611 | Recruiting |
| Boston University School of Medicine: Pulmonary Center | Boston | Massachusetts | 02118 | Recruiting |
| Boston Children's Hospital: Department of Immunology | Boston | Massachusetts | 02215 | Recruiting |
| Icahn School of Medicine at Mount Sinai: Division of Clinical Immunology, Immunology Institute | New York | New York | 10029 | Recruiting |
| Columbia University Medical Center: Division of Pediatric Pulmonology | New York | New York | 10032 | Recruiting |
| Cincinnati Children's Hospital Medical Center: Asthma Center | Cincinnati | Ohio | 45229 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06136091, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 30, 2026 · Synced Sep 4, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06136091 live on ClinicalTrials.gov.